Evidence map›Paper›PMID 30061808›Full record

ArticleMateria socio-medica2018

Extrapulmonary Tuberculosis in Federation of Bosnia and Herzegovina.

Vesna Cukic, Aida Ustamujic

Abstract read
In one paragraph

Article in Materia socio-medica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Vesna CukicClinic for pulmonary diseases and TB "Podhrastovi", Clinical centre of Sarajevo University, Bosnia and Herzegovina.
Aida UstamujicClinic for pulmonary diseases and TB "Podhrastovi", Clinical centre of Sarajevo University, Bosnia and Herzegovina.
University of Sarajevo · BA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHealth Introduction: The two types of tuberculosis (TB) are: pulmonary TB (PTB) and extrapulmonary TB (EPTB).

objectiveto represent the frequency of ETPB of all localization , ratio between EPTB and PTB and demographic characteristics of EPTB in FBiH in the period of four years : from 2014 to 2017. MATERIAL AND

methodsThis is the retrospective analysis of all the reported cases of TB in FBiH with the special insight in EPTB from 2014 to 2017. A standard set of data for TB patients is used which is included in the standardized form-"Minimum information for reporting tuberculosis" which has been used according to the recommendation of the WHO and IUATLD all over the Europe and elsewhere in the world.

resultswe registered 2588 patients with TB and among them there were 316 patients or 12.21% with EPTB. In the 2014 there were 795 cases of TB and of that 103 (13.0%) were EPTB ;in 2015 of 728 cases of TB 91 (12.5%) were EPTB ; in 2016 of 573 cases of TB 69 (12%) were ETPB ;2017 of 492 cases of TB 53 (11%) were ETPB. ETPB is more frequent in males but with no statistical significance. The most cases of EPTB were in the group of patients aged from 21 to 30 years because of frequency of tuberculous pleurisy. The tuberculous pleuritis is the most frequent form of ETPB (p<0.01).

conclusionThe frequency of TB and ETPB in FBiH decreases over the years. This indicates good control and therapeutic regimen of TB in FBiH. The ratio of PTB and EPTB remains approximately the same-about 12% of all TB cases are EPTB. Thus we are getting close to the situation in developed countries.

Indexed as

extrapulmonary TB (EPTB)FBiHpulmonary TB (PTB)

Identifiers

PMID30061808
PMCPMC6029912
OpenAlexW2808364940

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.